Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial

Olea, Julian et al. Previously presented at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, November 1-5, 2023